SCHEMBL6023657

SCHEMBL6023657

O=CC1c2ccccc2CC1O

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.37
MMP1 P03956 2/20 0.36
MMP2 P08253 2/20 0.36
MMP9 P14780 2/20 0.36
MMP8 P22894 2/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
AURKA O14965 1/20 0.35
RPS6KB1 P23443 1/20 0.35
KDM1A O60341 4/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNA4 P43681 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29646020 0.77 KDM1A (0.43) ANPEPGRIN2DGRIN3BGRIN1GRIN2A
Formamide SCHEMBL9732052 0.75 PRCP (0.36) ANPEPAURKARPS6KB1KDM1A
SCHEMBL29127675 0.74 SIGMAR1 (0.41) KDM1A
SCHEMBL9732048 0.73 NAMPT (0.32) MMP1MMP2MMP9MMP8AURKA
SCHEMBL8017605 0.73 NAMPT (0.43) MMP1MMP2MMP9MMP8AURKA
SCHEMBL13783748 0.73 NAMPT (0.43) MMP1MMP2MMP9MMP8AURKA
SCHEMBL8050161 0.73 NAMPT (0.43) MMP1MMP2MMP9MMP8AURKA
SCHEMBL8013654 0.73 NAMPT (0.43) MMP1MMP2MMP9MMP8AURKA
SCHEMBL8364875 0.73 PRCP (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3867845 0.73 ANPEP (0.42) ANPEPGRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7129263-B2 Preparation of 3-azabicyclo [3.1.0] hexane derivatives PFIZER INC. 2006-10-31 US disclosed
EP-1675829-A1 PREPARATION OF 3-AZABICYCLO [3.1.0] HEXANE DERIVATIVES Pfizer Products Inc. (US) 2006-07-05 EP disclosed
US-20050113437-A1 Preparation of 3-azabicyclo [3.1.0] hexane derivatives PFIZER INC. 2005-05-26 US disclosed
WO-2005037790-A1 PREPARATION OF 3-AZABICYCLO [3.1.0] HEXANE DERIVATIVES PFIZER PRODUCTS INC. (US) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113437-A1 Preparation of 3-azabicyclo [3.1.0] hexane derivatives ADH1C, ADH1A, ADH5 ANPEP 3702/4885MMP1 4281/4885MMP2 4848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.